# DESCRIPTION

## TECHNICAL FIELD

- introduce gene amplification technology

## BACKGROUND ART

- describe T cell and B cell immune system
- explain T cell receptor (TCR) and B cell receptor (BCR)
- detail TCR gene rearrangement
- describe diversity of TCR gene sequence
- explain CDR3 region of TCR
- describe BCR gene rearrangement
- detail diversity of BCR gene sequence
- explain class switch recombination
- describe somatic hypermutation
- explain TCR and BCR repertoire analysis
- describe conventional TCR repertoire analysis
- explain limitations of conventional analysis
- introduce next generation sequence analysis techniques

## SUMMARY OF INVENTION

### Solution to Problem

- introduce unbiased gene amplification technique
- describe limitations of conventional methods
- propose novel primer design for TCR or BCR genes
- outline amplification and sequencing process
- highlight advantages of novel method

### <In Silico>

- introduce TCR or BCR repertoire analysis technology
- motivate limitations of conventional homology search
- describe reference database preparation
- describe input sequence set preparation
- search for homology with reference database
- record alignment with closest reference allele
- select closest reference allele by indicators
- extract CDR3 sequence and translate to amino acid sequence
- classify D region by amino acid sequence
- calculate frequency of appearance for each region
- derive TCR or BCR repertoire
- describe method of analyzing TCR or BCR repertoire
- describe system for analyzing TCR or BCR repertoire
- describe computer program for analyzing TCR or BCR repertoire
- describe recording medium for storing computer program
- synthesize complementary DNA
- synthesize double stranded complementary DNA
- add adaptors to double stranded complementary DNA
- amplify genes using reverse primer
- design reverse primer for C region
- perform nested PCR
- describe method of preparing sample for quantitative analysis
- specify C region specific primer for BCR
- specify C region specific primer for TCR
- design common adaptor primer
- specify parameters for primer design
- determine sequences of TCR or BCR C region specific primers

### <Analysis System>

- provide nucleic acid sample
- determine nucleic acid sequence
- calculate frequency of gene appearance
- derive TCR or BCR repertoire
- perform single sequencing
- use common adaptor primer
- analyze disease based on repertoire
- treat or prevent disease
- provide kit for nucleic acid sample
- determine nucleic acid sequence
- calculate frequency of gene appearance
- derive TCR or BCR repertoire
- analyze disease based on repertoire
- treat or prevent disease
- describe monoclonal T cell
- describe various peptides and uses
- define MID Tag sequence
- specify C region specific primer for BCR
- specify C region specific primer for TCR
- design common adaptor primer
- specify primer settings for BCR and TCR analysis
- define analysis system
- specify primer design parameters
- determine primer sequences
- set primer positions
- specify primer structures
- perform gene analysis
- derive TCR or BCR repertoire
- provide reference database
- provide input sequence set
- search for homology
- assign V and J regions
- extract D region sequence
- translate and classify D region
- calculate frequency of appearance
- materialize processing by computer program

### <C1>

- analyze TCR/BCR repertoire

### <C2>

- determine candidate HLA test peptide

### <C3> <Improved CTL Method>

- mix peptide, antigen presenting cell, and CD8+ T cell

### <C4> <DC Vaccination Therapeutic Method>

- mix peptide with dendritic cell

### <C5> <Patient Autoimmune Cell Therapeutic Method>

- mix peptide, antigen presenting cell, and CD8+ T cell

### <D1> <Isolation of Tailor-Made Cancer Specific T Cell Receptor Gene, Isolation of Cancer Specific TCR Gene by In Vitro Antigen Stimulation>

- mix antigen peptide, inactivated cancer cell, and T lymphocyte
- analyze TCR of tumor specific T cell
- isolate desired tumor specific T cell
- mix inactivated cancer cell and antigen peptide
- mix lymphocyte, inactivated cancer cell, and T lymphocyte
- mix determined peptide, inactivated cancer cell, and T lymphocyte
- analyze TCR of tumor specific T cell
- isolate desired tumor specific T cell
- mix inactivated cancer cell and antigen peptide
- mix lymphocyte, inactivated cancer cell, and T lymphocyte
- mix determined peptide, inactivated cancer cell, and T lymphocyte
- isolate desired tumor specific T cell

## Advantageous Effects of Invention

- describe unbiased amplification
- motivate comprehensive analysis
- summarize advantages over conventional techniques
- describe estimation of TCRα and TCRβ gene pair
- highlight clinical applications

### <Wet Associated Effect>

- describe advantages in clinical applications

### <In Silico Associated Effect>

- compare with IMGT/High-V-QUEST

### <Effects Regarding Therapy>

- describe cancer idiotype peptide therapeutic method
- motivate safe therapy
- describe synergistic effect of tumor specific DC cell and CTL cell
- highlight tailor-made cancer TCR gene therapy

## DESCRIPTION OF EMBODIMENTS

- define singular expressions
- define database
- define genetic sequence analysis
- define T cell receptor (TCR)
- describe TCR structure
- define B cell receptor (BCR)
- describe BCR structure
- define V region
- define D region
- define J region
- define C region
- define repertoire of a variable region
- define quantitative analysis
- define sample
- define complementary DNA
- define double stranded complementary DNA
- define common adaptor primer sequence
- describe primer setting regions
- define IgG heavy chain sequence of BCR
- define IgD heavy chain sequence of BCR
- define IgE heavy chain sequence of BCR
- define Igκ chain constant region sequence of BCR
- define Igλ chain sequence of BCR
- define α sequence of TCR
- define β sequence of TCR
- define γ sequence of TCR
- define δ sequence of TCR
- define specific
- define sufficiently specific
- define first PCR amplification reaction
- define not homologous with other genetic sequences
- define second TCR or BCR C region specific primer
- define third PCR amplification reaction
- define third TCR or BCR C region specific primer
- define terms
- define complete match with all C region allelic sequences
- define unlikely to have homodimer and intramolecular hairpin structures
- define not having homodimer and intramolecular hairpin structures
- define can stably form a double strand
- define not highly homologous
- define same level of melting temperature (Tm)
- define base length suitable for amplification
- define mismatch
- define % GC (% guanine.cytosine content)
- define set compatible with all TCR or BCR subclasses
- define protein, polypeptide, oligopeptide, and peptide
- define amino acid
- define polynucleotide, oligonucleotide, and nucleic acid
- define purified substance
- define corresponding amino acid or nucleic acid
- define fragment
- define activity
- define expression
- define search
- define functional equivalent
- define marker
- define subject
- define sample
- define agent
- define detecting agent and diagnostic agent
- define complex, composite molecule, interaction, and bond
- define specific interaction
- describe detection and quantification methods
- define amount of expression
- define change in amount of expression
- define decrease and suppression
- define increase and activation
- describe detection of immune system condition
- define means
- describe nucleic acid primer
- describe primer set
- describe use of primer set in nucleic acid amplification
- define probe
- describe use of probe as marker detecting means
- describe labeling of detecting agent
- describe use of tag
- define test sample
- define diagnosis
- describe formulation procedure for diagnostic agent
- define complete match with all C region allelic sequences
- define trimming
- define suitable length
- define input sequence set
- define gene region and homology

### Preferred Embodiments

- introduce unbiased sample amplification
- describe next generation sequencing techniques
- motivate SMART PCR limitations
- describe limitations of SMART PCR
- introduce PCR amplification reaction steps
- describe first PCR amplification reaction
- describe second PCR amplification reaction
- describe third PCR amplification reaction
- specify C region specific primer design
- specify common adaptor primer design
- describe primer design parameters
- describe primer design conditions
- specify primer structure
- describe large-scale analysis
- introduce gene analysis method
- describe quantitative analysis of TCR or BCR repertoire
- introduce analysis system
- describe bioinformatics for TCR or BCR repertoire analysis
- provide reference database for gene regions
- provide input sequence set
- search for homology with reference database
- assign V and J regions and extract D region sequence
- translate D region sequence and classify
- introduce preferred embodiments
- provide input sequence set
- perform trimming and/or extraction
- perform alignment
- detect nucleic acid sequence information
- classify D region
- calculate frequency of appearance
- derive TCR or BCR repertoire
- describe gene region
- describe reference database
- describe unbiased sequence set
- describe trimming
- describe homology search
- describe classification of D region
- describe frequency of appearance
- describe system configuration
- describe gene analysis system
- describe repertoire analysis system
- describe repertoire analysis method
- provide nucleic acid sample
- determine nucleic acid sequence
- calculate frequency of appearance
- derive TCR or BCR repertoire
- define preferred embodiments
- describe single sequencing with common adaptor primer
- describe single sequencing with C region primer
- describe unbiased amplification
- describe analysis method for disease diagnosis
- describe linking read data with clinical information
- describe searching TCR with known function
- describe searching public database for antigen specificity
- describe associating sample origin with disease
- describe analyzing read frequency and clonality
- describe analyzing V chain and J chain usage frequency
- describe analyzing CDR3 sequence length and composition
- describe searching reads associated with disease onset
- describe calculating diversity index and similarity index
- describe associating diversity index with disease onset
- describe treatment system for disease prevention
- define disease embodiments
- introduce monoclonal T cell
- describe usefulness of T cell
- explain detection methods
- define detecting agent
- describe diagnostic agent
- define decrease and suppression
- define increase and activation
- explain agent detection
- define agent
- explain complex and composite molecule
- define interaction and bond
- explain specific interaction
- define antibody and antigen
- define primer
- describe primer sequence
- describe probe
- describe probe sequence
- define label
- describe labeling methods
- describe tag
- describe contact
- describe invariant TCR peptide
- describe MAIT cell TCR peptide
- describe NKT cell TCR peptide
- describe colorectal cancer-specific peptide
- describe cell population inducing T cell
- describe T cell cell line
- describe recombinantly expressed T cell
- describe analysis method
- describe V gene usage frequency
- describe J gene usage frequency
- describe subtype frequency analysis
- describe CDR3 sequence length pattern
- describe clonality analysis
- introduce Kimoto's Cπ index
- introduce Pianka's α index
- describe next generation sequencing techniques
- introduce cancer idiotype peptide sensitization immune cell therapeutic method
- describe method of preparing composition for cancer idiotype peptide sensitization immune cell therapeutic method
- determine TCR or BCR derived from cancer cell
- determine amino acid sequence of candidate HLA test peptide
- synthesize determined peptide
- describe cancer idiotype peptide sensitization immune cell therapeutic method in clinical practice
- describe improved CTL method
- describe DC vaccine therapy
- describe patient autoimmune cell therapeutic method
- describe method of applying cancer idiotype peptide sensitization immune cell therapeutic method
- describe method of manufacturing therapeutic agent
- describe method of therapy
- introduce BIMAS, SYFPEITHI, RANKPEP, and NetMHC
- describe isolation of tailor-made cancer specific T cell receptor gene
- describe isolation of cancer specific TCR gene by in vitro antigen stimulation
- describe method of preparing isolated cancer specific TCR gene
- describe therapy using isolated tailor-made cancer specific T cell receptor gene and cancer specific TCR gene
- describe isolation of tailor-made cancer specific T cell receptor gene by searching for a common sequence
- introduce preferred embodiments
- describe therapy using gene obtained by isolation of tailor-made cancer specific T cell receptor gene
- list various types of cancer that can be treated
- describe method of isolating cancer specific TCR gene by in vitro antigen stimulation
- describe method of isolating cancer specific TCR gene by searching for a common sequence
- introduce cell processing therapeutic method
- describe method of preparing T lymphocyte introduced with tumor specific TCR gene
- describe selection of optimal TCR and antigen
- describe production of tumor specific α and β TCR expression viral vector
- describe cell processing therapeutic method using T lymphocyte introduced with tumor specific TCR gene
- list various types of cancer that can be treated
- describe antigen stimulation methods
- describe efficacy and safety assessment methods
- describe method of assessing efficacy
- describe method of assessing safety
- introduce method of implementing cell processing therapeutic method
- describe method of introducing T lymphocyte introduced with tumor specific TCR gene into patient
- introduce isolation of human form antibody utilizing BCR repertoire analysis
- describe method of immunizing mouse with target antigen protein or peptide
- describe method of analyzing immunoglobulin heavy chain and light chain genes
- describe method of comparing genetic sequences and frequencies
- describe method of identifying immunoglobulin heavy chain and light chain genes
- describe method of selecting and inserting genes into antibody expression vector
- describe method of introducing expression vector into eukaryotic cell and culturing cell
- define peptide and nucleic acid
- describe peptide's ability to bind to MHC class II molecule
- define protein, polypeptide, oligopeptide, and peptide
- define polynucleotide, oligonucleotide, and nucleic acid
- define gene
- describe homology of genes
- describe calculation of homology
- define polynucleotide that hybridizes under stringent conditions
- describe conditions for hybridization
- define purified substance or biological agent
- define isolated substance or biological agent
- define fragment
- describe functional equivalent
- describe search for functional equivalent
- describe altered amino acid sequence
- define conservative substitution
- define subject
- define agent
- define therapy
- define therapeutic agent
- define prevention
- define prophylactic agent
- introduce peptide derived from antigen associated with tumorigenesis
- describe peptide synthesis and modification
- discuss pharmaceutical composition and excipients
- explain peptide optimization and stability
- introduce non-peptide bonds and retro-inverso peptidomimetics
- describe chemical modification of peptides
- discuss peptide synthesis and purification methods
- introduce nucleic acid encoding peptide or variant
- describe expression vector and host cell selection
- discuss regimen and administration of peptide or DNA vaccine
- explain selection and amount of peptides in pharmaceutical composition
- describe individualized vaccine composition
- discuss preferred vaccine composition and peptide length
- describe peptide embodiments
- discuss adjuvants for enhancing immunogenicity
- list examples of suitable adjuvants
- explain CpG immunostimulatory oligonucleotide
- describe other useful adjuvants
- discuss pharmaceutical composition administration
- describe excipients for pharmaceutical composition
- discuss cytotoxic T cell activation
- describe antigen-presenting cell
- discuss pharmaceutical composition administration methods
- describe tumor therapy using combination of drugs
- outline method of treating or preventing cancer
- describe pharmaceutical composition as anticancer vaccine
- discuss composition as tumor or cancer vaccine
- describe nucleic acid vaccine
- discuss delivery systems for nucleic acid vaccine
- explain mechanism of priming immune response
- introduce peptide vaccine
- describe administration methods
- motivate cancer diagnosis
- describe peptide detection methods
- analyze lymphocyte response
- generate antibodies
- describe therapeutic methods
- introduce kit composition
- describe kit components
- outline kit instructions
- describe pharmaceutical composition
- outline administration routes
- reference general techniques

## EXAMPLES

- introduce preparation examples of unbiasedly amplified samples

### (1. RNA Extraction)

- extract RNA from peripheral blood mononuclear cells

### (2. Synthesis of Complementary DNA and Double Stranded Complementary DNA)

- synthesize complementary DNA
- synthesize double stranded complementary DNA
- perform 5′ terminal blunting reaction
- purify double stranded DNA
- add P20EA/10EA adaptor
- perform ligation reaction
- digest adaptor added double stranded DNA
- purify double stranded DNA

### Preparation Example 2: Analysis of TCR Repertoire in Peripheral Blood of Healthy Individuals

- extract RNA from peripheral blood mononuclear cells
- synthesize complementary DNA and double stranded complementary DNA
- perform PCR amplification
- perform next generation sequencing
- analyze sequence data
- assign V, D, and J regions
- study usage frequency of V, D, and J chains

### Preparation Example 3: Amplification of TCR and BCR Genes by Unbiased Adaptor-Ligation PCR

- introduce sample preparation
- extract RNA from sample
- synthesize complementary DNA
- synthesize double-stranded complementary DNA
- perform ligation reaction
- digest adaptor-added DNA
- perform first PCR amplification
- perform nested PCR
- visualize amplicons
- show primer position with respect to template
- discuss significance of primer position
- conclude preparation example

## ANALYTICAL TEST EXAMPLE

### Analytical Test Example 1 BCR Repertoire Analysis on Healthy Individuals

- introduce BCR repertoire analysis
- describe method and results

### Analytical Test Example 2 Comparison of BCR Repertoire Among Specimens

- compare BCR repertoires among specimens

### Analytical Test Example 3: Comparison of TCR Repertoires of Healthy Individuals

- introduce TCR repertoire analysis
- describe materials and methods
- describe method for repertoire derivation
- show results of comparing TRAV and TRBV repertoires
- show results of comparing TRAJ and TRBJ repertoires
- discuss advantages of the present system

### 4. Next Generation Sequencing

- describe next generation sequencing method

### 5. Data Analysis

- describe data analysis method
- assign V, D, J, and C sequences
- describe frequency analysis of reads
- show results of TRA and TRB repertoire analysis
- show results of diversity index analysis
- discuss utility in diagnosis
- show distribution of unique reads
- show 3D plots of TRA and TRB repertoires

### 5. PCR

- describe PCR method

### 6. Next Generation Sequencing

- describe next generation sequencing method

### 7. Data Analysis

- describe data analysis method

### 8. Extraction of Overlapping Unique Reads in Analysis of 10 Healthy Individuals

- describe extraction of overlapping unique reads

### 9. Analysis of Overlapping Reads in TCRα Chain

- analyze overlapping reads in TCRα chain

### 10. Analysis of Overlapping Read in Colorectal Cancer Patient Tissue

- analyze overlapping reads in cancer patient tissue

### 11. Extraction of Cancer Specific TCR Sequence

- extract cancer specific TCR sequence

### (2. Synthesis of Complementary DNA and Double Stranded Complementary DNA)

- synthesize complementary DNA and double stranded complementary DNA

### (3. PCR)

- perform 1st PCR amplification
- perform 2nd and 3rd PCR amplification

### Enrichment

- enrich sample using Ion OneTouch ES

### Dispensing the Following Solution to Each Well of 8 Strip Tubes

- set up reagent
- initiate Ion OneTouch ES apparatus
- collect tubes containing ISP
- mix tubes gently
- use Ion PGM Sequencing 200 Kit v2
- understand alternative apparatus usage
- introduce example 4 of analysis system
- extract RNA from whole blood
- separate PBMC by ficoll density gradient centrifugation
- synthesize complementary DNA and double stranded complementary DNA
- perform 1st PCR amplification
- perform 2nd PCR amplification
- perform MiSeq dual-indexed paired-end sequencing
- purify PCR product by electrophoresis
- perform MiSeq sequencing
- introduce example 5 of analysis system
- describe high throughput sequence analysis method
- discuss limitations of multiple PCR
- describe adaptor-ligation mediated PCR
- discuss various sequencing techniques
- standardize sample size
- define Morisita-Horn index
- test statistical significance
- describe repertoire analysis software
- analyze number of reads and error rates
- express TCR gene comprising ORF and pseudogene
- analyze recombination of TRAV and TRAJ
- visualize TCR repertoire
- analyze CDR3 chain length distribution
- estimate diversity of TCRα and TCRβ repertoires
- compare similarity of TCRα and TCRβ repertoires among healthy individuals
- identify shared TCR sequences among healthy individuals
- characterize public TCRα sequences
- discuss advantages of adaptor-ligation mediated PCR
- compare results with previous reports
- discuss recombination of TRAV and TRAJ genes
- estimate potential TCR diversity
- compare diversity of TCRα and TCRβ
- discuss similarity of TCRα repertoires among individuals
- identify public TCRα sequences shared among individuals
- characterize public TCRα sequences with germ line-like CDR3
- discuss presence of invariant TCRα in public TCRα
- discuss importance of MAIT and iNKT cells
- summarize advantages of NGS-based TCR repertoire analysis

### Applied Example 1: Example of Antibody Isolation: Example of Isolation of Human Form Antibody Utilizing BCR Repertoire Analysis

- obtain human form anti-idiotype antibody using humanized NOG mice
- perform BCR repertoire analysis to identify immunoglobulin H chain and L chain genetic sequences
- construct antibody expressing plasmid and introduce into CHO cell
- express and purify antibody protein

### Applied Example 2: Cancer Idiotype Peptide Sensitization Immune Cell Therapeutic Method

- collect peripheral blood mononuclear cells from malignant lymphoma patient
- perform BCR repertoire analysis to identify BCR gene derived from tumor
- predict HLA-binding peptide using BIMAS program
- synthesize individualized cancer peptide and stimulate dendritic cells
- induce differentiation of dendritic cells and stimulate with peptide
- administer peptide-stimulated dendritic cells to patient

### (Discussion)

- discuss effects of present invention

### Applied Example 3: Improved CTL Method

- identify cancer idiotype peptide using BCR repertoire analysis
- stimulate CD8+ T cells with peptide and dendritic cells
- expand and culture CD8+ T cells
- administer CD8+ T cells to patient

### Applied Example 4: DC Vaccine Therapeutic Method

- identify cancer idiotype peptide using BCR repertoire analysis
- stimulate dendritic cells with peptide
- administer peptide-stimulated dendritic cells to patient

### Applied Example 5: Patient Autoimmune Cell Therapeutic Method

- identify cancer idiotype peptide
- synthesize and culture cells
- introduce cells into patient

### Applied Example 6: Isolation of Tailor-Made Cancer Specific T Cell Receptor Gene, Isolation of Cancer Specific TCR Gene by In Vitro Antigen Stimulation

- extract tumor cells and PBMC
- stimulate and culture cells
- extract RNA and perform repertoire analysis
- clone and introduce TCR genes into retrovirus
- infect lymphocytes with retrovirus and verify expression

### Applied Example 7: Preparation of Isolated Cancer Specific TCR Gene by In Vitro Antigen Stimulation

- extract tumor cells and PBMC
- extract RNA and perform repertoire analysis
- identify tumor specific TCR genes
- clone and introduce TCR genes into retrovirus
- infect lymphocytes with retrovirus and verify expression

### Applied Example 8: Cell Processing Therapeutic Method

- make retrovirus and introduce into lymphocytes
- mix lymphocytes with inactivated tumor cells and assess reactivity
- select lymphocytes with high reactivity and introduce into patient

### Applied Example 9: Method of Assessing Efficacy and/or Safety by In Vitro Stimulation Test

- make retrovirus and introduce into lymphocytes
- mix lymphocytes with inactivated tumor cells and assess reactivity
- assess efficacy by ELISPOT or other methods
- assess safety by reactivity to normal cells

### INDUSTRIAL APPLICABILITY

- useful in clinical applications for quantitative analysis and large scale gene analysis

